RSM logo
Laboratory Animals

Home Current issue Browse archive Alerts About the journal Feedback
 
This version was published on 1 July 2009
Lab Anim 2009;43:249-254
doi:10.1258/la.2008.008069
© 2009 Laboratory Animals Limited

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
la.2008.008069v1
43/3/249    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Jensen-Waern, M
Right arrow Articles by Essén-Gustavsson, B
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Articles

Effects of streptozotocin-induced diabetes in domestic pigs with focus on the amino acid metabolism

M Jensen-Waern 1 , M Andersson 1, R Kruse 1, B Nilsson 2, R Larsson 2, O Korsgren 2 and B Essén-Gustavsson 1

1 Department of Clinical Sciences, Section for Comparative Physiology and Medicine, SLU, PO Box 7054, 750 07 Uppsala, Sweden; 2 Section for Clinical Immunology, Uppsala University, Uppsala, Sweden

Corresponding author: Marianne Jensen-Waern. Email: Marianne.Jensen-Waern{at}kv.slu.se

Streptozotocin (STZ) given intravenously destroys pancreatic beta cells and is widely used in animal models to mimic type 1 diabetes. The effects of STZ on the clinical state of health and metabolism were studied in six high health certified domestic pigs weighing 19 ± 1.3 kg at the start of the experiment. A single STZ dose of 150 mg/kg of body weight successfully induced hyperglycaemia and alterations in amino acid metabolism. Within 9 h after STZ administration, the blood glucose values fell from 5.4–7.5 mmol/L to 0.8–2.2 mmol/L. Hypoglycaemia was treated with 0.5 g glucose/kg body weight. In all pigs, hyperglycaemia was produced 24 h after STZ treatment, and 3 days after STZ injection, the glucose concentration was >25 mmol/L. Mean C-peptide concentration was 0.25 ± 0.16 µg/L since 2 days after STZ injection until the end of the study. The serum concentration of the branched-chain amino acids (BCAA) increased four-fold, and alanine and taurine decreased by approximately 70% and 50%, respectively, after STZ treatment. All but one pig remained brisk and the physical examination was normal except for a retarded growth rate and a reduction of the skeletal muscle. At the end of the study, the pigs were moderately emaciated. Postmortem examination confirmed muscle wasting and a reduction of abdominal and subcutaneous fat. In conclusion, STZ-induced diabetes in pigs fulfils the requirements for a good animal model for type 1 diabetes with respect to clinical signs of the disease and alterations in the carbohydrate and amino acid metabolism.

Key Words: Swine • hyperglycaemia • muscle • alanine • branched-chain amino acids


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




How Not to be a Doctor